COVID 19 or CORONA: Aapda or Avasar for Pharmaceutical Industries? The worldwide pandemic (Aapda) of coronavirus disease, widely referred to as COVID-19, appeared as an Opportunity (Avasar) for the pharmaceutical industry. Apart from having a lot of pressure on the pharmaceutical industry to accelerate vaccines and treatments as soon as possible, the industry is also […]